Lecture 17: Adverse Drug Events, Hypersensitivity, Mutagenicity & Teratogenicity Notes

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/55

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:49 PM on 10/14/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

56 Terms

1
New cards

What is an adverse event (AE)?

Any harmful or negative outcome occurring while a patient receives medical care, including procedures, surgery, or medications

2
New cards

What is an adverse drug event (ADE)?

An injury resulting from medical intervention related to a drug.

3
New cards

What can ADEs include?

ADRs, allergic reactions, side effects, overmedication/overdose, and medication errors.

4
New cards

What is a medication error?

Inappropriate use of a drug that may or may not cause harm.

5
New cards

At which steps can medication errors occur?

Prescribing, transcribing, dispensing, administration, adherence, or monitoring.

6
New cards

What is an adverse drug reaction (ADR)?

Harm directly caused by a drug given at normal doses.

7
New cards

What factors increase ADR risk?

Advanced age, polypharmacy, dose, route, duration, bioavailability, sex, ethnicity, genetics, coexisting disease, and geographic factors.

8
New cards

What is the inpatient impact of ADEs?

About 1 in 3 hospital visits involves an AE; ADEs affect about 2 million hospital stays yearly and may extend stays by 1.7–4.6 days.

9
New cards

What is the outpatient impact of ADEs?

Over 3.5 million office visits, about 1 million ED visits, and about 125,000 hospital admissions yearly.

10
New cards

What are social determinants of health (SDOH)?

Nonmedical conditions that affect health, well-being, quality of life, medication access, and safe medication use.

11
New cards

What are examples of SDOH that can affect ADE risk?

Housing, transportation, income, education, food access, discrimination, pollution, language, and health literacy.

12
New cards

How can SDOH increase ADE risk?

Barriers such as limited transportation, low health literacy, or inability to afford medications can lead to medication errors or unsafe medication use.

13
New cards

What percentage of ADRs are Type A?

More than 80%.

14
New cards

What percentage of ADRs are Type B

Less than 20%.

15
New cards

How is Type A ADR pharmacology related?

It is related to the drug’s known pharmacologic effects.

16
New cards

How is Type B ADR pharmacology related?

It is not explained by the drug’s known pharmacology

17
New cards

Are Type A ADRs dose-dependent?

Yes—usually dose-dependent.

18
New cards

Are Type B ADRs dose-dependent?

Usually not; dose dependence is low.

19
New cards

What causes Type A ADRs?

Predictable pharmacologic actions, including ADME and receptor effects.

20
New cards

What causes Type B ADRs?

Off-target receptor activation, immune responses, or genetic susceptibility.

21
New cards

When do Type A ADRs usually occur?

Within hours to days.

22
New cards

When can Type B ADRs occur?

Immediately, after a delay, or variably

23
New cards

Who can experience a Type A ADR?

Anyone at a sufficiently high dose.

24
New cards

Who usually experiences a Type B ADR?

Susceptible individuals.

25
New cards

Compare morbidity and mortality of Type A vs. Type B ADRs.

Type A: higher morbidity but lower mortality. Type B: lower morbidity but potentially higher mortality.

26
New cards

What is a Type A drug overdose?

Toxicity caused by consuming an excessive amount of a drug.

27
New cards

Give examples of Type A overdose toxicity.

Acetaminophen → liver failure; warfarin → bleeding; opioids → respiratory depression.

28
New cards

What is a drug side effect?

A predictable, dose-dependent effect unrelated to the primary therapeutic effect.

29
New cards

Give examples of drug side effects.

NSAIDs → gastritis; aminoglycosides → nephrotoxicity; antibiotics → diarrhea; doxycycline → phototoxicity.

30
New cards

What is a drug interaction

When a drug’s effect is altered by another drug, food, supplement, or disease.

31
New cards

Give examples of Type A drug interactions.

Theophylline + macrolides; warfarin + vitamin K intake; benzodiazepines + opioids → respiratory depression.

32
New cards

What are Type B hypersensitivity reactions?

Immune or inflammatory reactions to a drug.

33
New cards

What are other immunologic Type B reactions?

Immune-mediated reactions that are not classic hypersensitivity, such as drug-induced autoimmune disease or fixed drug eruptions.

34
New cards

What is an idiosyncratic reaction?

An unpredictable reaction, often due to genetic variation.

35
New cards

What is an example of an idiosyncratic reaction?

Hemolysis from dapsone in a patient with G6PD deficiency.

36
New cards

What is a pseudoallergic reaction?

A reaction that resembles allergy but is not immune-mediated, often from direct mast-cell activation.

37
New cards

What are examples of pseudoallergic reactions?

Vancomycin infusion reaction; reactions to fluoroquinolones or neuromuscular blockers.

38
New cards

What is haptenation?

Covalent binding of a small drug molecule to a large protein, creating an immunogenic drug-protein complex.

39
New cards

What size are drugs that commonly act as haptens?

Usually less than 1,000 Da.

40
New cards

In which hypersensitivity type is haptenation especially important?

Type IV hypersensitivity, although it can also contribute to Types I–III.

41
New cards

What triggers mediator release in immediate hypersensitivity?

Cross-linking of adjacent IgE molecules bound to a cell by a free drug or drug-protein conjugate.

42
New cards

Why can beta-lactam antibiotics cause hypersensitivity?

Their strained beta-lactam rings can open and covalently bind proteins.

43
New cards

How can epoxides contribute to hypersensitivity?

They are electrophilic metabolites, often formed by aromatic epoxidation, that react with cellular nucleophiles/proteins.

44
New cards

How do α,β-unsaturated carbonyls react with proteins?

They react with thiol groups through Michael addition.

45
New cards

How do aromatic amines/anilines become reactive?

N-hydroxylation forms hydroxylamines, which can be oxidized to reactive nitroso compounds.

46
New cards

What do nitroso compounds react with on proteins?

Sulfhydryl (–SH) groups.

47
New cards

How can sulfhydryl-reactive metabolites contribute to hypersensitivity?

They bind cysteine thiols on proteins, altering protein function or creating antigenic complexes.

48
New cards

What is mutagenesis?

The ability of a chemical to cause DNA changes that are transmitted during cell division.

49
New cards

What is a germline mutation?

A mutation in sperm or ova that can be passed to future generations.

50
New cards

What is a somatic mutation?

A mutation in nonreproductive body cells that is not inherited by offspring but may cause cell death or pass to daughter cells during mitosis.

51
New cards

What common chemical groups can be mutagenic?

Epoxides, alkylating agents, DNA base analogs, aromatic amines/anilines, and planar PAHs.

52
New cards

What are nitrogen mustards, and how do they cause mutations?

Chloroethylamine-containing cytotoxic compounds that nonspecifically alkylate DNA, causing mutations and cell death.

53
New cards

How do DNA base analogs cause mutations?

They resemble normal purines or pyrimidines, become incorporated into DNA, and can pair incorrectly.

54
New cards

How does 5-bromouracil cause a mutation?

It can replace thymine; after tautomeric shift, it pairs with guanine and causes an A-T → G-C transition.

55
New cards

What are PAHs, and where are they found?

Mutagenic/carcinogenic products of incomplete combustion found in tobacco smoke, car exhaust, coal tar, asphalt production, and some foods.

56
New cards

What are the key teratogenesis and thalidomide facts?

A teratogen disrupts fetal development, especially during organogenesis (about day 20 through the end of the first trimester). Thalidomide’s S-enantiomer is teratogenic, R is sedating, and racemization means giving only R is not fully protective.